心理生理学症状缓解疗法 (PSRT) 治疗COVID-19后急性后果
Michael Donnino1,2, Patricia Howard1, Shivani Mehta1,3
1Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston MA, USA.
Mayo Clinic proceedings. Innovations, quality & outcomes
|June 26, 2023
概括
心理生理学症状缓解疗法 (PSRT) 有效地减少了COVID-19 (PASC) 后急性后续症患者的症状负担. 这种疗法提供了一种有希望的非药物治疗方法,可以在没有器官损伤的情况下管理长期的COVID症状.
科学领域:
- 医学研究 医学研究
- 治疗方法 治疗方法
- 在COVID-19研究研究.
背景情况:
- COVID-19 (PASC) 后急性后果是一个重大挑战,其特点是持续的症状.
- 许多PASC患者缺乏对器官损伤的客观证据,需要替代治疗策略.
- 目前对PASC症状的治疗仍然有限,特别是对于那些没有器官损伤的人来说.
研究的目的:
- 评估心理生理学症状缓解疗法 (PSRT) 在降低PASC患者症状负担方面的疗效.
- 评估PSRT对体征症状,呼吸不全,疲劳和疼痛的影响,在患有轻度/中度COVID-19病史的个人中.
- 为了确定PSRT是否是PASC患者可行的治疗方法,而没有客观的器官损伤证据.
主要方法:
- 一项干预性队列研究,涉及23名60岁以下的成人,患有PASC至少12周.
- 参与者接受了为期13周 (44小时) 的虚拟PSRT课程.
- 经过验证的问卷,包括人体症状量表-8 (SSS-8),在基线和4,8和13周时进行了管理.
主要成果:
- 在4,8和13周观察到平均SSS-8得分的统计学显著下降 (p<.001).
- 实体症状有所改善,平均SSS-8得分分别下降8.5,9.4和10.9在各自的时间点.
- 在二次结果中也记录了显著的改善,包括呼吸不良,疲劳和疼痛 (所有p<.001).
结论:
- 在PASC患者中,PSRT显示出作为一种有效疗法的潜力,可以降低PASC患者的症状负担.
- 研究结果表明,PSRT对患有PASC的个体有益,即使没有客观的器官损伤.
- 这项研究突出了治疗长期COVID症状的非药物治疗选择.
更多相关视频
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
836
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
749
相关概念视频
01:27Post-traumatic Stress Disorder
76
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
76
01:28Pleural Effusion II: Symptoms and Management
220
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
220
01:26Psychosis: Goals of Pharmacotherapy
171
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
171
01:20Desensitization and Tachyphylaxis
1.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.9K
01:28Acute Coronary Syndrome IV: Interprofessional Care
13
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
13
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K